In 1988, Wheeler et al. [8] reported that physicians treating patients for pulmonary embolism and deep-vein thrombosis frequently underdosed their patients and were slow to change their heparin ...

CHICAGO, IL — A small, single-center analysis suggests that it may be time to increase the recommended maximum, weight-based unfractionated-heparin bolus and infusion doses for patients with ACS so as ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to ...

Anecdotal reports of subtherapeutic heparin have kept many cardiologists across the world on edge over the past couple of months, although no regulatory authority has yet confirmed a specific problem.

SAN FRANCISCO, CALIF.—In a study of patients who received either bivalirudin or heparin for non-emergent, balloon aortic valvuloplasty, bivalirudin was associated with less bleeding, according to a ...

Heparin-induced thrombocytopenia (HIT) is a clinicopathologic syndrome in which one or more clinical events, usually thrombocytopenia or thrombosis, are temporally related to heparin administration ...

Company Provides Additional Instructions to Clinicians to Mitigate Risk of Reaction While Working to Identify Root Cause DEERFIELD, Ill., February 11, 2008 – Baxter Healthcare Corporation is ...

Please provide your email address to receive an email when new articles are posted on . Baxter Healthcare has temporarily stopped manufacturing multiple-dose vials of heparin due to reports of serious ...

CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with ...

CHICAGO (Reuters) - Baxter International Inc on Monday said it has temporarily stopped making the blood-thinner heparin in multi-dose vials after four patients who took the drug died and hundreds of ...